Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Invus US Partners LLC Insider Profile
4 Followers
Invus US Partners LLC, Director, Ten Percent Owner at Lexicon Pharmaceuticals, holds 5.78M shares in Lexicon Pharmaceuticals (Ticker: LXRX). Most recently, Invus US Partners LLC Bought $147,390 shares of Lexicon Pharmaceuticals on Aug 09, 2022 for an estimated value of 368.48K.
Invus US Partners LLC Lexicon Pharmaceuticals (LXRX)Director, Ten Percent Owner
Lexicon Pharmaceuticals (LXRX)
Director, Ten Percent Owner
Ranked #70,350 out of 98,501 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-25.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Invus US Partners LLC's holdings
Insider Roles
Director, Ten Percent Owner
Roles that Invus US Partners LLC holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 01, 2022 - Aug 01, 2023
Return:-18.10%
The most profitable trade made by Invus US Partners LLC
Invus US Partners LLC's Trading History
List of latest transactions for each holding click on a transaction to see Invus US Partners LLC's performance on stock
You May Also Like
Invus US Partners LLC insider profile FAQ
What is the percentage of profitable transactions made by Invus US Partners LLC?
The percentage of profitable transactions made by Invus US Partners LLC is 0%.
What is the average return per transaction made by Invus US Partners LLC?
The average return per transaction made by Invus US Partners LLC is -25.20%.
What stocks does Invus US Partners LLC hold?
Invus US Partners LLC holds: LXRX stocks.
What was Invus US Partners LLC’s latest transaction?
Invus US Partners LLC latest transaction was an Informative Buy of $368.48K.
What was Invus US Partners LLC's most profitable transaction?
Invus US Partners LLC’s most profitable transaction was an Informative Buy of LXRX stock on August 1, 2022. The return on the trade was -18.10%.
What is Invus US Partners LLC's role in Lexicon Pharmaceuticals?
Invus US Partners LLC's role in Lexicon Pharmaceuticals is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.